開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
據The Information:SpaceX的星鏈業務2025年營收增長50%,達到114億美元。
2026-04-14
據The Information:SpaceX的星鏈業務2025年營收增長50%,達到114億美元。
返回
其他消息
2026-04-14
IBM: MORGAN STANLEY CUTS TARGET PRICE TO $215.00 FROM $247.00
IBM: MORGAN STANLEY CUTS TARGET PRICE TO $215.00 FROM $247.00
2026-04-14
China will refine its drug pricing system with 14 measures, according to a State Council document released on Apr 14, Xinhua reported. Key steps include optimizing launch pricing for innovative and newly listed drugs, leveraging醫保 payment standards to guide pricing, and encouraging pharmacies to set reasonable retail prices, while strengthening supply and price stability for shortage medicines. The plan also calls for enhanced governance, including price risk monitoring and early-warning systems
China will refine its drug pricing system with 14 measures, according to a State Council document released on Apr 14, Xinhua reported. Key steps include optimizing launch pricing for innovative and newly listed drugs, leveraging醫保 payment standards to guide pricing, and encouraging pharmacies to set reasonable retail prices, while strengthening supply and price stability for shortage medicines. The plan also calls for enhanced governance, including price risk monitoring and early-warning systems, stricter enforcement against manipulation, full-chain audit oversight, and a drug value assessment system, aiming to keep prices within a reasonable range.
Chat with us
, powered by
LiveChat